Verastem (VSTM) EBIAT (2018 - 2025)
Verastem (VSTM) has 8 years of EBIAT data on record, last reported at -$32.9 million in Q4 2025.
- For Q4 2025, EBIAT rose 49.01% year-over-year to -$32.9 million; the TTM value through Dec 2025 reached -$209.5 million, down 60.35%, while the annual FY2025 figure was -$209.5 million, 60.35% down from the prior year.
- EBIAT reached -$32.9 million in Q4 2025 per VSTM's latest filing, up from -$98.5 million in the prior quarter.
- Across five years, EBIAT topped out at -$8.3 million in Q2 2024 and bottomed at -$98.5 million in Q3 2025.
- Average EBIAT over 5 years is -$28.6 million, with a median of -$22.4 million recorded in 2021.
- Peak YoY movement for EBIAT: soared 66.0% in 2024, then plummeted 311.06% in 2025.
- A 5-year view of EBIAT shows it stood at -$16.5 million in 2021, then fell by 1.98% to -$16.8 million in 2022, then crashed by 62.83% to -$27.4 million in 2023, then plummeted by 135.86% to -$64.6 million in 2024, then skyrocketed by 49.01% to -$32.9 million in 2025.
- Per Business Quant database, its latest 3 readings for EBIAT were -$32.9 million in Q4 2025, -$98.5 million in Q3 2025, and -$25.9 million in Q2 2025.